Changes in Sensitivity, Taste and Smell in Stroke Patients (5S)

November 30, 2023 updated by: Tobias Braun, University of Giessen

Changes in Sensitivity of Swallowing-relevant Structures, Taste and Smell in Stroke Patients

This study evaluates changes in swallowing using endoscopic swallowing studies and measuring of pharyngeal sensitivity, taste and smell in stroke patients. Younger (<60 years) and older (>60 years) volunteers will serve as control.

Study Overview

Detailed Description

Stroke is the second leading cause of death. At least 50% of stroke patients develop dysphagia, leading to aspiration pneumonia, which is the main cause of death in stroke [2].

It is assumed that normal sensitivity is vital for aspiration-free swallowing and for the triggering of the swallowing reflex.

Ali et al. demonstrated aspiration-free swallowing in healthy volunteers who underwent local anaesthesia of oral and pharyngeal structures [1]. Power et al. showed a reduced sensitivity of pharyngeal structures in stroke patients prone to aspiration [3].

By combining measuring sensitivity and flexible endoscopic swallowing studies, this study further investigates the role of sensitivity in swallowing Neuropsychological deficits of swallowing, such as swallowing apraxia or buccal hemineglect, is assessed by neuropsychological testing.

Additionally, there is no systematic research investigating the change in smell and taste in correlation with changes in stroke patients

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Stroke patients are recruited in a university hospital's department of neurology.

Volunteers >60years are recruited in a trauma surgery ward at the same university hospital.

Volunteers <60 are recruited without specified characteristics (aside from in-/exclusion criteria).

Description

Inclusion Criteria:

Volunteers:

  • informed consent

Stroke patients:

  • informed consent
  • new supratentorial stroke (<72 hours old) confirmed by CT (computed tomography) or MRI (magnetic resonance imaging)

Exclusion Criteria:

  • pre-existing stroke oder dysphagia
  • extensive white matter lesions in CT- or MRI-scan
  • allergies to odorous substances or flavoring
  • contraindications for FEES (flexible endoscopic evaluation of swallowing), CT or MRI (stroke patients only)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Volunteers <60 years
Volunteers, who are able to consent to participation in the study, as control.
Determining sensitivity threshold using a pudendal electrode
Taste-/smell-test
Volunteers >60 years
Volunteers, who are able to consent to participation in the study, as control.
Determining sensitivity threshold using a pudendal electrode
Taste-/smell-test
Stroke patients
Stroke patients with supratentorial stroke, who are able to consent to participation in the study.
Determining sensitivity threshold using a pudendal electrode
Taste-/smell-test
Endoscopical swallowing study in stroke patients only
Neuropsychological testing for neglect, agnosia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dysphagia
Time Frame: 96 hours after initial symptoms

Changes found in endoscopic swallowing study :

Presence and severity of dysphagia (measured with Rosenbek's Penetration/Aspiration-scale)

96 hours after initial symptoms

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neuropsychological deficits
Time Frame: 96 hours after initial symptoms
Agnosia, neglect
96 hours after initial symptoms
Lesion site
Time Frame: 96 hours after initial symptoms
Side, vascular territory, swallowing relevant structures
96 hours after initial symptoms
Sensitivity
Time Frame: 96 hours after initial symptoms
Sensitivity of faucial pillar region
96 hours after initial symptoms
Taste/Smell
Time Frame: 96 hours after initial symptoms
Smell-/Taste-score
96 hours after initial symptoms

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tobias Braun, M.D., University Giessen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2017

Primary Completion (Estimated)

February 1, 2025

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

July 28, 2017

First Submitted That Met QC Criteria

August 1, 2017

First Posted (Actual)

August 7, 2017

Study Record Updates

Last Update Posted (Estimated)

December 1, 2023

Last Update Submitted That Met QC Criteria

November 30, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Sensitivity threshold

3
Subscribe